Back to Search

A Phase II Study of Checkpoint Blockade Immunotherapy in Patients With Somatically Hypermutated Recurrent WHO Grade 4 Glioma


  • Protocol Number: 202012180
  • Principal Investigator: Johanns, Tanner
  • Cancer Types: Neurological

For more information on this trial, contact us here:

Phone
800-600-3606
Email
[email protected]

Brief Summary

Protocol Interventions